{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:37:10Z","timestamp":1767494230721,"version":"3.40.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.burns.2018.10.024","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T18:44:58Z","timestamp":1544467498000},"page":"891-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence of oxandrolone induced hepatic transaminitis in patients with burn injury"],"prefix":"10.1016","volume":"45","author":[{"given":"Brittany","family":"Kiracofe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6929-7322","authenticated-orcid":false,"given":"Larry M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Kevin","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheela","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire V.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2018.10.024_bib0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.burns.2015.08.023","article-title":"The efficacy and safety of oxandrolone treatment for patients with severe burn: a systematic review and meta-analysis","volume":"42","author":"Hui","year":"2016","journal-title":"Burns"},{"key":"10.1016\/j.burns.2018.10.024_bib0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.BCR.0000202620.55751.4F","article-title":"Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial","volume":"27","author":"Wolf","year":"2006","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.burns.2018.10.024_bib0015","first-page":"54","article-title":"The beneficial effects of the anabolic steroid oxandrolone in the geriatric burn population","volume":"15","author":"Demling","year":"2003","journal-title":"Wound"},{"key":"10.1016\/j.burns.2018.10.024_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0305-4179(98)00159-4","article-title":"Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury","volume":"25","author":"Demling","year":"1999","journal-title":"Burns"},{"key":"10.1016\/j.burns.2018.10.024_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/BCR.0B013E318053D257","article-title":"Incidence of hepatic dysfunction is equivalent in burn patients receiving oxandrolone and controls","volume":"28","author":"McCullough","year":"2007","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.burns.2018.10.024_bib0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1592\/phco.29.2.213","article-title":"Oxandrolone treatment in adults with severe thermal injury","volume":"29","author":"Miller","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.burns.2018.10.024_bib0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200464070-00004","article-title":"The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders","volume":"64","author":"Orr","year":"2004","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.burns.2018.10.024_bib0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1378\/chest.122.2.421","article-title":"Reversal of COPD-associated weight loss using the anabolic agent oxandrolone","volume":"122","author":"Yeh","year":"2002","journal-title":"Chest"},{"issue":"14","key":"10.1016\/j.burns.2018.10.024_bib0045","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.281.14.1282","article-title":"Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss","volume":"284","author":"Strawford","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.burns.2018.10.024_bib0050","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutrition support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a department of veterans affairs cooperative study","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.burns.2018.10.024_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1517\/14656566.4.3.369","article-title":"Current pharmacotherapy for the treatment of severe burns","volume":"4","author":"Murphy","year":"2003","journal-title":"Expert Opin Pharmacother"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417918302870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417918302870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T03:03:36Z","timestamp":1557889416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417918302870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0305417918302870"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2018.10.024","relation":{},"ISSN":["0305-4179"],"issn-type":[{"type":"print","value":"0305-4179"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of oxandrolone induced hepatic transaminitis in patients with burn injury","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2018.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}